APA (7th ed.) Citation

N, M., M, V., Y, V., ME, P., F, V., S, C., & R, L. (2015). Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 17(11), 856. https://doi.org/10.1007/s12094-015-1314-y

Chicago Style (17th ed.) Citation

N, Martínez-Lago, Vieito-Villar M, Vidal-Insua Y, Padin-Iruegas ME, Vazquez-Rivera F, Candamio-Folgar S, and Lopez-Lopez R. "Adjuvant Treatment with Infusional 5-fluorouracil in High Risk Adenocarcinoma of the Stomach or Gastroesophageal Junction." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 17, no. 11 (2015): 856. https://doi.org/10.1007/s12094-015-1314-y.

MLA (9th ed.) Citation

N, Martínez-Lago, et al. "Adjuvant Treatment with Infusional 5-fluorouracil in High Risk Adenocarcinoma of the Stomach or Gastroesophageal Junction." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 17, no. 11, 2015, p. 856, https://doi.org/10.1007/s12094-015-1314-y.